Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Brand Name
Sorbitol-mannitol
Generic Name
Sorbitol And Mannitol
Active Ingredient
MannitolCategory
Osmotic Diuretic [EPC]
Variants
1
Different strengths and dosage forms
| Strength | Form | Route | NDC |
|---|---|---|---|
| .54 g/100mL | IRRIGANT | URETHRAL | 0990-7981 |
Detailed information about Sorbitol-mannitol
This page is for informational purposes only and does not replace medical advice. Before using any prescription or over-the-counter medication for Sorbitol-mannitol, you must consult a qualified healthcare professional.
Mannitol is a potent osmotic diuretic and diagnostic agent used primarily to reduce intracranial pressure, treat cerebral edema, and promote the excretion of toxic substances. It works by creating an osmotic gradient that draws fluid from tissues into the vascular space for renal elimination.
Dosage for Mannitol is highly individualized and depends strictly on the condition being treated, the patient's fluid status, and their kidney function. Healthcare providers typically use the following ranges:
Mannitol is used in children, but the dosage must be calculated precisely based on body weight or body surface area.
In patients with severe renal impairment (kidney failure), Mannitol can accumulate in the blood, leading to a dangerous condition called hyperosmolality. If a patient does not respond to a test dose of Mannitol with increased urine output, further doses should generally be withheld. For patients with mild to moderate impairment, doses are reduced and the interval between doses is increased.
While Mannitol is not significantly metabolized by the liver, patients with hepatic impairment often have associated fluid balance issues (like ascites). In these cases, Mannitol must be used with caution to avoid worsening fluid shifts.
Older adults are more likely to have reduced kidney function and a higher prevalence of heart disease. Healthcare providers typically start at the lower end of the dosing range and monitor heart and kidney function closely to prevent fluid overload or congestive heart failure.
Mannitol is almost exclusively administered by a healthcare professional in a clinical setting.
Since Mannitol is typically administered in a hospital for acute conditions, a missed dose is unlikely. If a scheduled dose is delayed, the clinical team will assess the patient's current pressure levels and fluid status to determine the next appropriate step. Patients should not attempt to "make up" a dose if they are using the inhaled form at home without consulting their doctor.
An overdose of Mannitol leads to a massive shift of intracellular water into the vascular space, causing "cellular dehydration" and "vascular overload."
> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose without medical guidance. Mannitol is a potent medication that requires professional oversight.
Because Mannitol causes rapid shifts in body fluids, side effects are common, especially during the initial phase of the infusion. These include:
> Warning: Stop taking Mannitol and call your doctor immediately if you experience any of these.
Mannitol is rarely used as a long-term treatment. However, in cases where it is used repeatedly (such as for chronic management of certain brain conditions), the following may occur:
No FDA black box warnings for Mannitol currently exist. However, the FDA does mandate strong precautions regarding its use in patients with pre-existing kidney or heart disease. The risk of pulmonary edema and acute fluid overload is considered the most significant clinical danger associated with the drug.
Report any unusual symptoms to your healthcare provider. Because Mannitol is usually given in a hospital, nurses will be monitoring your vital signs, heart rhythm, and urine output every hour to catch these side effects early.
Mannitol is a high-alert medication that must be used with extreme caution. The most critical safety point is the management of fluid balance. Mannitol does not just "remove" water from the body; it moves it from one place (cells) to another (bloodstream) before it is excreted. This temporary increase in blood volume can be dangerous for patients with heart or lung conditions. Patients must be closely monitored for "fluid overload," which can lead to heart failure or pulmonary edema. Additionally, Mannitol can mask or worsen dehydration if not balanced with appropriate IV fluids.
No FDA black box warnings for Mannitol. While it lacks a black box warning, its potential for causing rapid, life-threatening fluid shifts is treated with the same level of clinical gravity as drugs that do have such warnings.
Patients receiving Mannitol require intensive monitoring, often in an ICU or step-down unit:
Since Mannitol is administered in a hospital for acute, often life-threatening conditions, patients will not be in a position to drive. If using the inhaled form for a diagnostic test, patients should wait until any dizziness or lightheadedness has completely resolved before attempting to drive.
Alcohol should be strictly avoided during and immediately after Mannitol therapy. Alcohol is itself a diuretic and can worsen the dehydration and electrolyte imbalances caused by Mannitol. Furthermore, alcohol can interfere with the assessment of a patient's neurological status, which is critical when treating the conditions for which Mannitol is prescribed.
Mannitol should not be stopped abruptly if it has been used for an extended period to control brain pressure. Tapering the dose or increasing the time between doses helps prevent "rebound" brain swelling. Your doctor will determine the safest way to transition you off the medication.
> Important: Discuss all your medical conditions with your healthcare provider before starting Mannitol, especially if you have a history of heart failure, kidney disease, or asthma.
While there are few drugs that are strictly contraindicated due to chemical incompatibility, certain combinations are avoided due to extreme risk:
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking. Even "natural" products can change how your body responds to an osmotic diuretic.
Mannitol must NEVER be used in the following circumstances:
In these cases, the doctor will weigh the benefits against the significant risks:
Patients with a known hypersensitivity to Mannitol should not receive the drug. While Mannitol is a naturally occurring sugar alcohol, synthetic versions used in IV solutions may contain stabilizers or be derived from sources that cause rare allergic reactions. There is no major cross-sensitivity with common drugs like sulfa or penicillin, but any history of reacting to IV sugar solutions (like sorbitol) should be reported.
> Important: Your healthcare provider will evaluate your complete medical history, including your heart and kidney function, before prescribing Mannitol.
Mannitol is classified as FDA Pregnancy Category C. This means that adequate and well-controlled studies in humans are lacking. Animal reproduction studies have not been extensively conducted. However, the primary concern is the rapid shift in fluid and electrolytes, which could potentially affect placental blood flow or fetal hydration. Mannitol should be used during pregnancy only if clearly needed and if the life-saving benefits for the mother (such as treating a brain injury) outweigh the risks to the fetus. There is no evidence of teratogenicity (birth defects), but the clinical data is limited.
It is not known whether Mannitol is excreted in human milk. Because many drugs are excreted in human milk and because of the potential for serious adverse reactions in nursing infants from Mannitol, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother. In most acute cases where Mannitol is used, breastfeeding is temporarily paused due to the mother's critical condition.
Mannitol is used in pediatric patients for the same indications as adults (ICP and IOP reduction). However, safety and effectiveness in children under the age of 12 for certain indications have not been as extensively documented in clinical trials. In children, the fluid and electrolyte balance is much more fragile. Small errors in dosing can lead to significant complications. Therefore, pediatric dosing is strictly weight-based, and children must be monitored in an intensive care environment with frequent blood gas and electrolyte checks.
Clinical studies of Mannitol did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects. However, it is well-known that elderly patients are more likely to have decreased renal function. Since Mannitol is primarily excreted by the kidneys, the risk of toxic reactions is greater in this population. Doctors typically select doses for elderly patients with caution, usually starting at the low end of the range and monitoring kidney function (creatinine clearance) more frequently.
In patients with renal impairment, the half-life of Mannitol is prolonged. If the kidneys cannot filter the Mannitol, it remains in the blood, drawing water out of the cells and into the vascular space indefinitely. This can lead to "hyperosmolar syndrome," which causes mental status changes and can be fatal. For patients with a GFR (Glomerular Filtration Rate) below 30 mL/min, Mannitol is generally avoided unless a test dose proves the kidneys are still responsive.
No specific dose adjustments are provided for hepatic impairment, as the liver does not significantly metabolize Mannitol. However, these patients often have low protein levels (hypoalbuminemia) and altered fluid dynamics. This makes them more susceptible to the side effects of fluid shifts. Monitoring of central venous pressure (CVP) may be necessary in these patients during Mannitol infusion.
> Important: Special populations require individualized medical assessment and often require more frequent laboratory monitoring to ensure safety.
Mannitol is an osmotic diuretic that is pharmacologically inert in humans. Its primary molecular mechanism is the creation of an osmotic gradient. When present in high concentrations in the vascular space, it increases the osmolarity of the blood. This creates a physical force that draws water across semi-permeable membranes (like cell walls and the blood-brain barrier) from the intracellular and interstitial compartments into the intravascular space.
In the kidneys, Mannitol is filtered at the glomerulus but is not reabsorbed by the renal tubules. This increases the osmotic pressure of the glomerular filtrate. This pressure inhibits the tubular reabsorption of water and solutes (specifically sodium and chloride) in the proximal tubule and the ascending limb of the loop of Henle. The result is a significant increase in the excretion of water, sodium, and to a lesser extent, potassium and magnesium.
| Parameter | Value |
|---|---|
| Bioavailability | 100% (IV); <20% (Oral) |
| Protein Binding | 0% (Does not bind to plasma proteins) |
| Half-life | 70-100 minutes (Normal Renal Function) |
| Tmax | End of infusion (IV) |
| Metabolism | Minimal (<10% in liver) |
| Excretion | Renal 80-90% (Unchanged) |
Mannitol belongs to the class of Osmotic Diuretics. It is distinct from other diuretics like Thiazides (which act on the distal tubule) or Loop Diuretics (which act on the loop of Henle) because its primary action is physical/osmotic rather than biochemical. Related medications in this class include Glycerin and Urea, though Mannitol is the most commonly used for systemic osmotic therapy.
Common questions about Sorbitol-mannitol
Mannitol is primarily used in emergency and critical care settings to reduce high pressure inside the brain (intracranial pressure) and the eyes (intraocular pressure). It is also used to help the kidneys produce urine in patients with acute kidney failure and to speed up the removal of toxic substances from the body during an overdose. By creating an osmotic gradient, it pulls excess fluid from tissues into the bloodstream to be filtered out by the kidneys. Additionally, an inhaled form is used as a diagnostic tool for asthma or to help clear mucus in patients with cystic fibrosis. It is a vital medication for managing cerebral edema and acute glaucoma.
The most common side effects of Mannitol include headache, nausea, vomiting, and extreme thirst. These occur because the medication causes rapid shifts in the body's fluid balance and electrolyte levels. Many patients also experience dizziness or blurred vision during the infusion process. Because Mannitol is a diuretic, increased urination is expected and is actually a sign that the medication is working. In some cases, patients may feel pain or irritation at the site where the IV is inserted. Most of these effects are temporary and resolve once the infusion is complete and fluid levels stabilize.
No, you should not drink alcohol while being treated with Mannitol. Alcohol is a natural diuretic and can worsen the dehydration and electrolyte imbalances that Mannitol causes. Since Mannitol is typically used for serious conditions like brain swelling or kidney issues, alcohol can also interfere with your doctor's ability to monitor your neurological status and recovery. Drinking alcohol while on this medication could lead to a dangerous drop in blood pressure or severe dizziness. Always wait until your doctor confirms that your fluid levels have returned to normal before consuming alcohol. In most cases, patients receiving Mannitol are in a hospital setting where alcohol is prohibited.
Mannitol is classified as Pregnancy Category C, meaning its safety during pregnancy has not been fully established through human clinical trials. It should only be used if the potential benefits to the mother, such as treating life-threatening brain pressure, clearly outweigh the risks to the developing fetus. The main concern during pregnancy is that the rapid fluid shifts could affect blood flow to the placenta or the baby's own hydration. There is no definitive evidence that Mannitol causes birth defects, but it is used with extreme caution. If you are pregnant or planning to become pregnant, your healthcare provider will carefully weigh the risks before administering this drug. Breastfeeding is also generally discouraged while receiving acute Mannitol therapy.
Mannitol works very quickly when administered intravenously. For the reduction of intracranial pressure (brain swelling), the effects usually begin within 15 to 30 minutes of starting the infusion. The peak effect of the medication typically occurs about 1 to 2 hours after the dose is given. For the reduction of eye pressure, the onset is similarly fast, usually within 30 to 60 minutes. The diuretic effect, which increases urine production, may take slightly longer, often starting within 1 to 3 hours. Because of its rapid onset, it is an essential tool for managing medical emergencies where every minute counts.
Mannitol is usually given as a series of infusions in a hospital, rather than a long-term daily medication. However, if it has been used repeatedly to manage brain pressure, stopping it suddenly can be dangerous. This is because a 'rebound effect' can occur, where the pressure inside the brain rises rapidly to levels even higher than before the treatment started. To prevent this, healthcare providers typically taper the dose or increase the time between infusions as the patient improves. You should never attempt to stop any treatment involving Mannitol on your own; your medical team will decide the best schedule for discontinuation based on your monitoring results.
In a hospital setting, your nurses and doctors are responsible for your Mannitol schedule, so a missed dose is very rare. If you believe a dose was missed, you should notify your healthcare provider immediately. They will assess your current condition, such as your neurological status or eye pressure, and determine if the dose should be given right away or adjusted. For the inhaled form used at home for cystic fibrosis, if you miss a dose, take it as soon as you remember. However, if it is almost time for your next dose, skip the missed one and return to your regular schedule. Never double the dose to make up for a missed one.
Mannitol does not cause weight gain; in fact, it usually causes temporary weight loss. Because Mannitol is a potent diuretic, it causes the body to lose a significant amount of water through increased urination. This loss of 'water weight' happens quickly during treatment. However, this is not a fat-loss effect and is not a healthy or permanent way to lose weight. Once the medication is stopped and you begin drinking fluids normally, your weight will likely return to its previous level. Any sudden weight gain while taking Mannitol would be a cause for concern, as it might indicate that your kidneys are not working properly and your body is retaining fluid.
Mannitol can interact with several other medications, so it is crucial to tell your doctor about everything you are taking. It can be particularly dangerous when combined with other diuretics, as this can lead to severe dehydration. It may also interact with blood pressure medications, lithium, and certain antibiotics like gentamicin. Because Mannitol changes the levels of electrolytes like potassium in your blood, it can make heart medications like digoxin more toxic. Your healthcare team will monitor your blood work and vital signs closely to manage these interactions. Always provide a full list of prescriptions, over-the-counter drugs, and herbal supplements to your medical team.
Yes, Mannitol is available as a generic medication and is produced by several different pharmaceutical manufacturers. It is a relatively inexpensive and widely available drug in hospital pharmacies. The generic version is just as effective as any brand-name version for reducing brain or eye pressure and promoting diuresis. In its intravenous form, it is usually referred to simply as 'Mannitol Injection' followed by the concentration (e.g., Mannitol 20%). The inhaled form used for cystic fibrosis may be sold under brand names like Bronchitol. Regardless of the name, the active ingredient remains the same and performs the same osmotic functions in the body.
Other drugs with the same active ingredient (Mannitol)